Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-18 Sale |
2024-03-20 4:32 pm |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
6,547 | $3.0169 | $19,752 | 123,896 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 6:14 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
28,600 | $4.6204 | $132,143 | 169,938 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-08 06:04 am |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
743 | $3.0925 | $2,298 | 204,943 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-08 06:03 am |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
3,740 | $3.0849 | $11,537 | 244,438 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-08 06:03 am |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
2,413 | $3.1189 | $7,526 | 154,152 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-08 06:02 am |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
11,686 | $3.1189 | $36,447 | 690,894 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-08 06:02 am |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
4,081 | $3.0877 | $12,601 | 207,234 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-08 06:00 am |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
3,740 | $3.0849 | $11,537 | 178,138 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-02 7:44 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
32,983 | $3.2746 | $108,006 | 400,580 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-13 4:45 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
33,839 | $3.4139 | $115,522 | 164,978 (Direct) |
View |
| 2023-08-08 Sale |
2023-08-10 4:11 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
60,000 | $1.9996 | $119,974 | 358,286 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-07 4:08 pm |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
355 | $2.4537 | $871 | 55,945 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-07 4:08 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
1,361 | $2.4537 | $3,339 | 70,078 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-07 4:08 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
1,361 | $2.4537 | $3,339 | 136,378 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-07 4:07 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
2,719 | $2.4537 | $6,672 | 433,563 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 8:26 pm |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
2,368 | $5.5238 | $13,080 | 102,420 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 8:26 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
2,368 | $5.5238 | $13,080 | 72,139 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 8:25 pm |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
820 | $5.5756 | $4,572 | 53,400 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 8:25 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
2,368 | $5.5238 | $13,080 | 138,439 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 8:25 pm |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
2,368 | $5.5238 | $13,080 | 76,787 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 8:23 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
37,626 | $5.8129 | $218,714 | 437,582 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-20 Option Award |
2024-03-22 4:08 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
37,500 | $0 | 161,396 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-13 6:14 pm |
N/A 2025-02-27 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
28,600 | $0 | 169,938 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-13 6:14 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
28,600 | $0.3 | 169,938 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-08 06:04 am |
N/A 2034-01-03 |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
111,800 | $0 | 204,943 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-08 06:03 am |
N/A 2034-01-03 |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel |
83,850 | $0 | 134,026 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-08 06:03 am |
N/A 2034-01-03 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
111,800 | $0 | 244,438 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-08 06:03 am |
N/A 2034-01-03 |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
100,620 | $0 | 154,152 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-08 06:02 am |
N/A 2034-01-03 |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
302,000 | $0 | 690,894 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-08 06:02 am |
N/A 2034-01-03 |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
134,160 | $0 | 207,234 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-08 06:00 am |
N/A 2034-01-03 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
111,800 | $0 | 178,138 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 4:45 pm |
N/A 2025-02-27 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
33,839 | $0 | 164,978 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 4:45 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
12,400 | $0.3 | 164,978 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 4:45 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
21,439 | $0.39 | 164,978 (Direct) |
View |
| 2023-08-08 Exercise |
2023-08-10 4:11 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
60,000 | $0 | 358,286 (Direct) |
View |
| 2023-08-08 Exercise |
2023-08-10 4:11 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
2,714 | $0.3 | 358,286 (Direct) |
View |
| 2023-08-08 Exercise |
2023-08-10 4:11 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
57,286 | $0.39 | 358,286 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:07 pm |
N/A 2033-06-15 |
G1 Therapeutics Inc. | GTHX | Sharpless Norman Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:07 pm |
N/A 2033-06-15 |
G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director |
40,000 | $0 | 55,889 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:07 pm |
N/A 2033-06-15 |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
40,000 | $0 | 225,358 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:06 pm |
N/A 2033-06-15 |
G1 Therapeutics Inc. | GTHX | Lee Jacks Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:06 pm |
N/A 2033-06-15 |
G1 Therapeutics Inc. | GTHX | Secor Alicia Director |
40,000 | $0 | 50,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:06 pm |
N/A 2033-06-15 |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
40,000 | $0 | 54,389 (Direct) |
View |
Ownership |
2023-05-24 4:41 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel |
0 | $0 | 176 (Direct) |
View |
| 2023-05-22 Option Award |
2023-05-24 4:41 pm |
N/A 2033-05-22 |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel |
200,000 | $0 | 200,176 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:20 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
35,000 | $0 | 71,439 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:20 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
35,000 | $0 | 77,155 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:19 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
35,000 | $0 | 137,739 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:19 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer |
35,000 | $0 | 93,886 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:19 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
35,000 | $0 | 56,300 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:16 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
160,000 | $0 | 436,282 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:20 pm |
N/A 2033-03-15 |
G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer |
150,000 | $0 | 158,886 (Direct) |
View |
Ownership |
2023-03-17 4:10 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer |
0 | $0 | 42,136 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:26 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
66,900 | $0 | 102,420 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:26 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
53,600 | $0 | 72,139 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:25 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
48,200 | $0 | 53,400 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:25 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
53,600 | $0 | 138,439 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:25 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
61,700 | $0 | 83,255 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:25 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
53,600 | $0 | 76,787 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:23 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
242,000 | $0 | 437,582 (Direct) |
View |